Paul Tudor Jones Dyne Therapeutics, Inc. Transaction History

Tudor Investment Corp Et Al

$26.8 Billion
Q3 2024

A detailed history of Paul Tudor Jones (Tudor Investment Corp Et Al) transactions in Dyne Therapeutics, Inc. stock. As of the latest transaction made, Tudor Investment Corp Et Al holds 50,483 shares of DYN stock, worth $1.21 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

50,483

Previous 47,069 7.25%

Holding current value

$1.21 Million

Previous $1.66 Million 9.15%

% of portfolio

0.01%

Previous 0.01%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$31.94 - $47.04 $109,043 - $160,594	3,414 Added 7.25%	50,483 $1.81 Million
Q2 2024 Aug 14, 2024	SELL	$23.65 - $35.63 $233,945 - $352,451	-9,892 Reduced 17.37%	47,069 $1.66 Million
Q1 2024 May 15, 2024	BUY	$13.06 - $29.18 $743,910 - $1.66 Million	56,961 New	56,961 $1.62 Million
Q1 2023 May 15, 2023	BUY	$10.88 - $15.0 $8,116 - $11,190	746 Added 1.24%	61,003 $703,000
Q4 2022 Feb 14, 2023	BUY	$9.37 - $13.8 $319,114 - $469,986	34,057 Added 129.99%	60,257 $698,000
Q3 2022 Nov 14, 2022	SELL	$7.2 - $15.17 $315,813 - $665,401	-43,863 Reduced 62.61%	26,200 $333,000
Q2 2022 Aug 15, 2022	BUY	$4.36 - $10.5 $65,103 - $156,786	14,932 Added 27.08%	70,063 $481,000
Q1 2022 May 16, 2022	BUY	$6.52 - $12.27 $104,424 - $196,516	16,016 Added 40.95%	55,131 $531,000
Q4 2021 Feb 14, 2022	BUY	$11.89 - $16.07 $465,077 - $628,578	39,115 New	39,115 $465,000
Q3 2021 Nov 15, 2021	SELL	$15.6 - $21.46 $362,388 - $498,515	-23,230 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$15.94 - $22.33 $805,416 - $1.13 Million	-50,528 Reduced 68.51%	23,230 $489,000
Q1 2021 May 17, 2021	BUY	$14.0 - $29.3 $881,888 - $1.85 Million	62,992 Added 585.1%	73,758 $1.15 Million
Q4 2020 Feb 16, 2021	SELL	$16.81 - $23.94 $45,521 - $64,829	-2,708 Reduced 20.1%	10,766 $226,000
Q3 2020 Nov 16, 2020	BUY	$20.0 - $23.9 $269,480 - $322,028	13,474 New	13,474 $272,000

Others Institutions Holding DYN

# of Institutions

209

Shares Held

102M

Call Options Held

234K

Put Options Held

238K

View Full List

About Dyne Therapeutics, Inc.

Ticker DYN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 51,765,400
Market Cap $1.24B
Description
Dyne Therapeutics, Inc., a muscle disease company, operates as a biotechnology company that focuses on advancing therapeutics for genetically driven muscle diseases in the United States. It develops various programs for myotonic dystrophy type 1, duchenne muscular dystrophy, and facioscapulohumeral dystrophy, as well as rare skeletal muscle, and...

More about DYN

Track Paul Tudor Jones's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tudor Investment Corp Et Al, based on Form 13F filings with the SEC.

News

Stay updated on Tudor Investment Corp Et Al and Paul Tudor Jones with notifications on news.

Account